| Dr Jennifer Imara Hayes-bethel, MD | |
|
8 Town Center Dr, Bowling Green, MO 63334-2803 | |
| (573) 324-2241 | |
| (573) 324-2617 |
| Full Name | Dr Jennifer Imara Hayes-bethel |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 8 Town Center Dr, Bowling Green, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467650101 | NPI | - | NPPES |
| 1467650101 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2010003211 (Missouri) | Primary |
| Entity Name | Md Now Medical Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033195474 PECOS PAC ID: 3971554825 Enrollment ID: O20050208000625 |
News Archive
A new gene mutation identified by researchers at Baylor College of Medicine in Houston is part of the constellation of genes associated with susceptibility to developing type 1 diabetes. It could also play a role in the devastating complications of diabetes such as kidney failure.
Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of motor neuron disorders - such as Lou Gehrig's disease and spinal muscular atrophy - to a new, comprehensive perspective.
Health Endeavors releases web-based ACO Audit Program to assist healthcare providers in achieving PQRS quality measures and ACO success.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
› Verified 7 days ago
| Entity Name | Foundcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215182712 PECOS PAC ID: 7911043542 Enrollment ID: O20091012000436 |
News Archive
A new gene mutation identified by researchers at Baylor College of Medicine in Houston is part of the constellation of genes associated with susceptibility to developing type 1 diabetes. It could also play a role in the devastating complications of diabetes such as kidney failure.
Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of motor neuron disorders - such as Lou Gehrig's disease and spinal muscular atrophy - to a new, comprehensive perspective.
Health Endeavors releases web-based ACO Audit Program to assist healthcare providers in achieving PQRS quality measures and ACO success.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Imara Hayes-bethel, MD 8 Town Center Dr, Bowling Green, MO 63334-2803 Ph: (573) 324-2241 | Dr Jennifer Imara Hayes-bethel, MD 8 Town Center Dr, Bowling Green, MO 63334-2803 Ph: (573) 324-2241 |
News Archive
A new gene mutation identified by researchers at Baylor College of Medicine in Houston is part of the constellation of genes associated with susceptibility to developing type 1 diabetes. It could also play a role in the devastating complications of diabetes such as kidney failure.
Investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute have received a grant from the National Institutes of Health to participate in a consortium taking the study of motor neuron disorders - such as Lou Gehrig's disease and spinal muscular atrophy - to a new, comprehensive perspective.
Health Endeavors releases web-based ACO Audit Program to assist healthcare providers in achieving PQRS quality measures and ACO success.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
› Verified 7 days ago
Dr. Donald Albert Miller, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-9854 | |
Dr. Dorothy E Swingle, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 S Business 61, Bowling Green, MO 63334 Phone: 573-324-2063 Fax: 573-324-2167 | |
Dr. Cole Joseph Scherder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-8964 | |
Brandon C.w. Brown, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-2617 | |
Kelly Marie Miller, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1420 S Business 61 Ste Def, Bowling Green, MO 63334 Phone: 573-324-5562 | |
Dr. Michael H. Whitlock, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1420 S Business 61 Ste Def, Bowling Green, MO 63334 Phone: 573-324-5562 |